| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 17, 2022 | ECOR Electrocore, Inc. | Gandolfo John P | Director | Buy | 15,000 | $0.36 | $5,400.00 | +375.0% | +63.8% | +4.9% | |
| May 17, 2022 | OM Outset Medical, Inc. | Trigg Leslie84 | Chair And CEO | Sell | 909 | $26.36 | $23,961.24 | -0.3% | -16.9% | -23.0% | |
| May 17, 2022 | TNDM Tandem Diabetes Care Inc | Blickenstaff Kim D61 | Director | Sell | 10,762 | $92.91 | $999,897.42 | -5.0% | -26.0% | -59.3% | |
| May 17, 2022 | HOLX Hologic Inc | Verstreken Jan | Group President, International | Sell | 6,500 | $78.80 | $512,167.50 | -9.2% | -7.1% | +2.5% | |
| May 17, 2022 | SONX Sonendo, Inc. | Bihl Anthony P III | Director | Buy | 20,000 | $2.90 | $58,000.00 | +43.5% | - | - | |
| May 17, 2022 | HOLX Hologic Inc | Cohn Benjamin Jordan63 | Principal Accounting Officer | Sell | 3,844 | $78.75 | $302,730.38 | -22.1% | -7.1% | +2.5% | |
| May 17, 2022 | SONX Sonendo, Inc. | Smith Michael John | Chief Commercial Officer | Buy | 21,468 | $2.79 | $59,957.64 | +3.1% | - | - | |
| May 17, 2022 | SGHT Sight Sciences, Inc. | Encrantz Staffan75 | Director, 10% Owner | Buy | 551,802 | $8.33 | $4,598,106.94 | +181.8% | +0.8% | +11.2% | |
| May 17, 2022 | CNMD Conmed Corp | Lande Jerome J. | Director | Sell | 7,521 | $115.74 | $870,492.60 | -54.3% | -12.1% | +1.6% | |
| May 16, 2022 | AHCO Adapthealth Corp. | Skyknight Capital Fund Ii, L.P.53 | Director | Buy | 21,632 | $16.20 | $350,498.97 | +0.8% | +40.4% | -32.9% | |
| May 16, 2022 | ECOR Electrocore, Inc. | Goldberger Daniel S69 | Chief Executive Officer | Buy | 28,208 | $0.34 | $9,585.08 | +9.4% | +96.4% | +21.0% | |
| May 16, 2022 | RBOT Vicarious Surgical Inc. | Khalifa Sammy84 | Chief Technology Officer | Sell | 4,551 | $3.79 | $17,271.05 | -3.2% | +29.2% | -46.6% | |
| May 16, 2022 | HAE Haemonetics Corp | Llorens Josep59 | EVP, Global Manufacturing | Sell | 107 | $56.10 | $6,002.70 | -0.7% | +31.7% | +54.9% | |
| May 16, 2022 | BSX Boston Scientific Corp | Carruthers Wendy | EVP, Human Resources | Sell | 7,500 | $39.43 | $295,725.00 | -5.1% | +5.9% | +35.0% | |
| May 16, 2022 | SIBN Si-Bone, Inc. | Francis Laura70 | Chief Executive Officer | Sell | 4,805 | $12.58 | $60,450.26 | -0.2% | +36.7% | +98.0% | |
| May 16, 2022 | PRCT Procept Biorobotics Corp | Nouri Alaleh50 | EVP, CLO, Corp. Sec. | Sell | 678 | $35.06 | $23,770.68 | -1.4% | +27.5% | -6.2% | |
| May 16, 2022 | SIBN Si-Bone, Inc. | Recupero Anthony J63 | President, Commercial Ops | Sell | 5,466 | $12.58 | $68,766.11 | -0.8% | +36.7% | +98.0% | |
| May 16, 2022 | BNGO Bionano Genomics, Inc. | Barker David L | Director | Buy | 10,000 | $1.60 | $16,000.00 | +256.8% | +129.3% | -58.2% | |
| May 16, 2022 | SIBN Si-Bone, Inc. | Pisetsky Michael A68 | SVP, Ops &Adm/ Chief Legal Ofr | Sell | 3,466 | $12.58 | $43,604.71 | -0.6% | +36.7% | +98.0% | |
| May 16, 2022 | HAE Haemonetics Corp | Miller Laurie A. | SVP, Human Resources | Sell | 31 | $56.10 | $1,739.10 | -0.3% | +31.7% | +54.9% | |
| May 16, 2022 | CTSO Cytosorbents Corp | Jones Edward Raymond | Director | Buy | 1,676 | $2.24 | $3,748.54 | +2.1% | -10.8% | +60.1% | |
| May 16, 2022 | SONX Sonendo, Inc. | Bergheim Bjarne | President And CEO | Buy | 30,000 | $2.95 | $88,500.00 | +3.6% | - | - | |
| May 16, 2022 | RPID Rapid Micro Biosystems, Inc. | Spignesi Robert G. Jr.53 | President And CEO | Buy | 10,000 | $3.80 | $37,950.00 | +5.4% | +0.3% | -76.4% | |
| May 16, 2022 | HAE Haemonetics Corp | Goldstein Dan | VP, Corporate Controller | Sell | 50 | $56.10 | $2,805.00 | -1.2% | +31.7% | +54.9% | |
| May 16, 2022 | DCTH Delcath Systems, Inc. | Purpura John49 | Chief Operating Officer | Buy | 3,300 | $4.61 | $15,213.00 | +13.9% | -4.1% | +32.0% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.